{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:25:42Z","timestamp":1792783542467,"version":"4.5.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"European Union Next Generation NRRP M6C2 Investment 2.1","award":["European Union Next Generation NRRP M6C2 Investment 2.1"],"award-info":[{"award-number":["European Union Next Generation NRRP M6C2 Investment 2.1"]}],"id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-026-02950-z","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:25:28Z","timestamp":1782123928000},"page":"3091-3094","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and effectiveness of setmelanotide in young patients with severe obesity due to craniopharyngioma: a real world monocentric experience"],"prefix":"10.1007","volume":"49","author":[{"given":"Oana Ruxandra","family":"Cotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Morgante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Giandalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Angileri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ferrau\u2019","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cannavo\u2019","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"2950_CR1","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/oby.23447","volume":"30","author":"J Wu","year":"2022","unstructured":"Wu J, Fu J, Huang ZJ et al (2022) Postoperative hypothalamic damage predicts postoperative weight gain in patients with adult-onset craniopharyngioma. Obes (Silver Spring) 30:1357\u20131369. https:\/\/doi.org\/10.1002\/oby.23447","journal-title":"Obes (Silver Spring)"},{"key":"2950_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/ejendo\/lvae044","volume":"190","author":"S Rovani","year":"2024","unstructured":"Rovani S, Butler V, Samara-Boustani D et al (2024) Long-term weight gain in children with craniopharyngioma. Eur J Endocrinol 190:363\u2013373. https:\/\/doi.org\/10.1093\/ejendo\/lvae044","journal-title":"Eur J Endocrinol"},{"key":"2950_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S2213-8587(24)00283-3","volume":"13","author":"J Argente","year":"2025","unstructured":"Argente J, Farooqi IS, Chowen JA et al (2025) Hypothalamic obesity: from basic mechanisms to clinical perspectives. Lancet Diabetes Endocrinol 13:57\u201368. https:\/\/doi.org\/10.1016\/S2213-8587(24)00283-3","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2950_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1530\/eje.0.1380089","volume":"138","author":"C Roth","year":"1998","unstructured":"Roth C, Wilken B, Hanefeld F et al (1998) Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. Eur J Endocrinol 138:89\u201391. https:\/\/doi.org\/10.1530\/eje.0.1380089","journal-title":"Eur J Endocrinol"},{"key":"2950_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/dom.70216","volume":"28","author":"F Lambert","year":"2026","unstructured":"Lambert F, Guillon E, Gatta-Cherifi B et al (2026) Effectiveness and safety of GLP-1 receptor agonists in craniopharyngioma patients with obesity: A multicentre real-world study. Diabetes Obes Metab 28:443\u2013451. https:\/\/doi.org\/10.1111\/dom.70216","journal-title":"Diabetes Obes Metab"},{"key":"2950_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/dom.14224","volume":"23","author":"CL Roth","year":"2021","unstructured":"Roth CL, Perez FA, Whitlock KB et al (2021) A phase 3 randomized clinical trial using a once-weekly glucagon-like peptide-1 receptor agonist in adolescents and young adults with hypothalamic obesity. Diabetes Obes Metab 23:363\u2013373. https:\/\/doi.org\/10.1111\/dom.14224","journal-title":"Diabetes Obes Metab"},{"key":"2950_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S2213-8587(24)00087-1","volume":"12","author":"CL Roth","year":"2024","unstructured":"Roth CL, Scimia C, Shoemaker AH et al (2024) Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial. Lancet Diabetes Endocrinol 12:380\u2013389. https:\/\/doi.org\/10.1016\/S2213-8587(24)00087-1","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2950_CR8","doi-asserted-by":"publisher","first-page":"106161","DOI":"10.1016\/j.appet.2022.106161","volume":"178","author":"S Zorn","year":"2022","unstructured":"Zorn S, von Schnurbein J, Schirmer M et al (2022) Measuring hyperphagia in patients with monogenic and syndromic obesity. Appetite 178:106161. https:\/\/doi.org\/10.1016\/j.appet.2022.106161","journal-title":"Appetite"},{"key":"2950_CR9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S2213-8587(22)00277-7","volume":"10","author":"AM Haqq","year":"2022","unstructured":"Haqq AM, Chung WK, Dollfus H et al (2022) Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alstr\u00f6m syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period. Lancet Diabetes Endocrinol 10:859\u2013868. https:\/\/doi.org\/10.1016\/S2213-8587(22)00277-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2950_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S2213-8587(24)00273-0","volume":"13","author":"J Argente","year":"2025","unstructured":"Argente J, Verge CF, Okorie U et al (2025) Setmelanotide in patients aged 2\u20135 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial. Lancet Diabetes Endocrinol 13:29\u201337. https:\/\/doi.org\/10.1016\/S2213-8587(24)00273-0","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2950_CR11","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S2213-8587(20)30364-8","volume":"8","author":"K Cl\u00e9ment","year":"2020","unstructured":"Cl\u00e9ment K, van den Akker E, Argente J et al (2020) Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials. Lancet Diabetes Endocrinol 8:960\u2013970. https:\/\/doi.org\/10.1016\/S2213-8587(20)30364-8","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2950_CR12","doi-asserted-by":"publisher","unstructured":"Phillips SA, van Santen HM, Hamilton JK et al (2025) OR11-01 Efficacy And Safety Of Setmelanotide In Acquired Hypothalamic Obesity: Results From A Double-blind, Multicenter, Placebo-controlled, Randomized Phase 3 Trial. J Endocr Soc 9. https:\/\/doi.org\/10.1210\/jendso\/bvaf149.074","DOI":"10.1210\/jendso\/bvaf149.074"},{"key":"2950_CR13","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.110.OC15.1","author":"P Faucher","year":"2025","unstructured":"Faucher P, Chalopin S, Albarel F et al (2025) Real-world setmelanotide changes in BMI in French patients with acquired hypothalamic obesity. Endocr Abstracts. https:\/\/doi.org\/10.1530\/endoabs.110.OC15.1","journal-title":"Endocr Abstracts"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02950-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02950-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02950-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:33:35Z","timestamp":1790757215000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-02950-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":13,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2950"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-02950-z","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}